GCIA
AMRI

Gabelli & Co Investment Advisers’s Albany Molecular Research Inc AMRI Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-48,859
Closed -$1.06M – 181
2017
Q2 		$1.06M Buy
+48,859
New +$887K 0.11% 77

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Gabelli & Co Investment Advisers's AMRI Position: Q3 2017 in Review

Gabelli & Co Investment Advisers sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 48,859 shares — an estimated $1.06M sold.

Gabelli & Co Investment Advisers first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $1.06M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Gabelli & Co Investment Advisers reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 48,859 Albany Molecular Research Inc shares in Q3 2017, an estimated $1.06M.
  • Gabelli & Co Investment Advisers first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Albany Molecular Research Inc position peaked at $1.06M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2017, filed 1 Nov 2017.